Evidence map›Paper›PMID 21835915›Full record

ArticleThe Journal of biological chemistry2011

Multiple glycogen-binding sites in eukaryotic glycogen synthase are required for high catalytic efficiency toward glycogen.

Sulochanadevi Baskaran, Vimbai M Chikwana, Christopher J Contreras, Keri D Davis, Wayne A Wilson, Anna A DePaoli-Roach, Peter J Roach, Thomas D Hurley

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sulochanadevi BaskaranDepartment of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
Vimbai M Chikwana
Christopher J Contreras
Keri D Davis
Wayne A Wilson
Anna A DePaoli-Roach
Peter J Roach
Thomas D Hurley
Indiana University – Purdue University Indianapolis · USDes Moines University · USIndiana University School of Medicine

Funding

RESEARCH TRAINING PROGRAM IN DIABETES AND OBESITYT32DK064466 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Carmella Evans-Molina, RONALD C WEK · 2003 to 2026
$5.2M
HORMONAL CONTROL OF GLYCOGEN METABOLISMR37DK027221 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI ROACH, PETER J · 1992 to 2014
$5.2M
Glycogen Metabolism and Lafora DiseaseR01NS056454 · NINDS · INDIANA UNIVERSITY INDIANAPOLIS · PI ROACH, PETER J · 2009 to 2018
$3.4M
Structural Determinants of Glycogen Synthase RegulationR01DK079887 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI HURLEY, THOMAS D. · 2011 to 2014
$1.4M
X8 Prospector for Macromolecular CrystallographyS10RR027281 · NCRR · INDIANA UNIVERSITY INDIANAPOLIS · PI HURLEY, THOMAS D. · 2011 to 2011
$453k
Novel mechanisms that regulate glycogen storage in Saccharomyces cerevisiaeR15GM081810 · NIGMS · DES MOINES UNIV OSTEOPATHIC MEDICAL CTR · PI WILSON, WAYNE ARTHUR · 2008 to 2008
$194k
NCRR NIH HHS S10 RR027281NIDDK NIH HHS R01 DK079887NIDDK NIH HHS R01-DK079887NIDDK NIH HHS R37 DK027221NIDDK NIH HHS R37-DK027221NIDDK NIH HHS T32 DK064466NIGMS NIH HHS R15 GM081810NIGMS NIH HHS R15-GM081810NINDS NIH HHS R01 NS056454NINDS NIH HHS R01-NS056454
6 · The paper itself

Abstract

Glycogen synthase is a rate-limiting enzyme in the biosynthesis of glycogen and has an essential role in glucose homeostasis. The three-dimensional structures of yeast glycogen synthase (Gsy2p) complexed with maltooctaose identified four conserved maltodextrin-binding sites distributed across the surface of the enzyme. Site-1 is positioned on the N-terminal domain, site-2 and site-3 are present on the C-terminal domain, and site-4 is located in an interdomain cleft adjacent to the active site. Mutation of these surface sites decreased glycogen binding and catalytic efficiency toward glycogen. Mutations within site-1 and site-2 reduced the V(max)/S(0.5) for glycogen by 40- and 70-fold, respectively. Combined mutation of site-1 and site-2 decreased the V(max)/S(0.5) for glycogen by >3000-fold. Consistent with the in vitro data, glycogen accumulation in glycogen synthase-deficient yeast cells (Δgsy1-gsy2) transformed with the site-1, site-2, combined site-1/site-2, or site-4 mutant form of Gsy2p was decreased by up to 40-fold. In contrast to the glycogen results, the ability to utilize maltooctaose as an in vitro substrate was unaffected in the site-2 mutant, moderately affected in the site-1 mutant, and almost completely abolished in the site-4 mutant. These data show that the ability to utilize maltooctaose as a substrate can be independent of the ability to utilize glycogen. Our data support the hypothesis that site-1 and site-2 provide a "toehold mechanism," keeping glycogen synthase tightly associated with the glycogen particle, whereas site-4 is more closely associated with positioning of the nonreducing end during catalysis.

Indexed as

Binding SitesGlycogenGlycogen SynthaseMutationOligosaccharidesProtein Structure, QuaternaryProtein Structure, TertiarySaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsGlycogenGlycogen SynthasemaltooctaoseOligosaccharidesSaccharomyces cerevisiae Proteins

Identifiers

PMID21835915
PMCPMC3190777
OpenAlexW1984645285

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.